773 related articles for article (PubMed ID: 17605154)
1. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
[TBL] [Abstract][Full Text] [Related]
2. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
3. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
4. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
Sakono M; Zako T; Ueda H; Yohda M; Maeda M
FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
[TBL] [Abstract][Full Text] [Related]
5. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils.
Okada T; Ikeda K; Wakabayashi M; Ogawa M; Matsuzaki K
J Mol Biol; 2008 Oct; 382(4):1066-74. PubMed ID: 18692507
[TBL] [Abstract][Full Text] [Related]
6. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
Päiviö A; Jarvet J; Gräslund A; Lannfelt L; Westlind-Danielsson A
J Mol Biol; 2004 May; 339(1):145-59. PubMed ID: 15123427
[TBL] [Abstract][Full Text] [Related]
7. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers.
Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL
Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493
[TBL] [Abstract][Full Text] [Related]
8. A disulfide-linked amyloid-beta peptide dimer forms a protofibril-like oligomer through a distinct pathway from amyloid fibril formation.
Yamaguchi T; Yagi H; Goto Y; Matsuzaki K; Hoshino M
Biochemistry; 2010 Aug; 49(33):7100-7. PubMed ID: 20666485
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
[TBL] [Abstract][Full Text] [Related]
10. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.
Sciarretta KL; Boire A; Gordon DJ; Meredith SC
Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983
[TBL] [Abstract][Full Text] [Related]
11. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
12. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
[TBL] [Abstract][Full Text] [Related]
13. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
Microsc Res Tech; 2005 Jul; 67(3-4):164-74. PubMed ID: 16103999
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy.
Tjernberg LO; Pramanik A; Björling S; Thyberg P; Thyberg J; Nordstedt C; Berndt KD; Terenius L; Rigler R
Chem Biol; 1999 Jan; 6(1):53-62. PubMed ID: 9889152
[TBL] [Abstract][Full Text] [Related]
16. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.
Moss MA; Varvel NH; Nichols MR; Reed DK; Rosenberry TL
Mol Pharmacol; 2004 Sep; 66(3):592-600. PubMed ID: 15322251
[TBL] [Abstract][Full Text] [Related]
17. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
20. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
